Quest Diagnostics 2026 shareholder voting results filed
Quest Diagnostics reported the results of its 2026 Annual Meeting of Stockholders held on May 20, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quest Diagnostics reported the results of its 2026 Annual Meeting of Stockholders held on May 20, 2026. All nominated directors were elected for terms expiring at the 2027 annual meeting, each receiving substantially more votes "for" than "against".
Stockholders approved the advisory resolution on executive officer compensation and ratified the appointment of PricewaterhouseCoopers as the company’s independent registered public accounting firm for 2026. A stockholder proposal requesting an independent board chairman did not receive sufficient support and was not approved.
8-K Event Classification
Key Figures
Key Terms
Annual Meeting of Stockholders financial
advisory resolution financial
independent registered public accounting firm financial
stockholder proposal financial
emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Quest Diagnostics (DGX) stockholders vote on at the 2026 annual meeting?
Were all Quest Diagnostics (DGX) director nominees elected in 2026?
Which audit firm did Quest Diagnostics (DGX) stockholders ratify for 2026?
What happened to the Quest Diagnostics (DGX) proposal for an independent board chairman?
When was the 2026 Quest Diagnostics (DGX) Annual Meeting of Stockholders held?
AI-generated analysis. How Rhea-AI works. Not financial advice.